NCT00088491

Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in Patients With Schizophrenia

A Double-Blind, Randomized Study Comparing Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in the Maintenance Therapy of Patients With Schizophrenia

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 1,205 (actual)
• Sponsor: Eli Lilly and Company · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This is a randomized, double-blind study to determine how well intramuscular (IM) olanzapine depot works compared to oral olanzapine; evaluate the safety and tolerability of IM olanzapine depot compared to oral olanzapine; evaluate different doses of IM olanzapine depot; and determine the blood levels of IM olanzapine depot in patients at different points in time after an injection.

Conditions

• Schizophrenic Disorders

Interventions

Type	Name	Description
DRUG	Intramuscular Olanzapine Depot
DRUG	Oral Olanzapine

Timeline

• Start date: 2004-06-01
• Completion: 2006-10-01
• First posted: 2004-07-28
• Last updated: 2007-06-22

Locations

4 sites across 2 countries: Finland, Turkey (Türkiye)